» Articles » PMID: 35328638

INSIDIA 2.0 High-Throughput Analysis of 3D Cancer Models: Multiparametric Quantification of Graphene Quantum Dots Photothermal Therapy for Glioblastoma and Pancreatic Cancer

Abstract

Cancer spheroids are in vitro 3D models that became crucial in nanomaterials science thanks to the possibility of performing high throughput screening of nanoparticles and combined nanoparticle-drug therapies on in vitro models. However, most of the current spheroid analysis methods involve manual steps. This is a time-consuming process and is extremely liable to the variability of individual operators. For this reason, rapid, user-friendly, ready-to-use, high-throughput image analysis software is necessary. In this work, we report the INSIDIA 2.0 macro, which offers researchers high-throughput and high content quantitative analysis of in vitro 3D cancer cell spheroids and allows advanced parametrization of the expanding and invading cancer cellular mass. INSIDIA has been implemented to provide in-depth morphologic analysis and has been used for the analysis of the effect of graphene quantum dots photothermal therapy on glioblastoma (U87) and pancreatic cancer (PANC-1) spheroids. Thanks to INSIDIA 2.0 analysis, two types of effects have been observed: In U87 spheroids, death is accompanied by a decrease in area of the entire spheroid, with a decrease in entropy due to the generation of a high uniform density spheroid core. On the other hand, PANC-1 spheroids' death caused by nanoparticle photothermal disruption is accompanied with an overall increase in area and entropy due to the progressive loss of integrity and increase in variability of spheroid texture. We have summarized these effects in a quantitative parameter of spheroid disruption demonstrating that INSIDIA 2.0 multiparametric analysis can be used to quantify cell death in a non-invasive, fast, and high-throughput fashion.

Citing Articles

Towards a more objective and high-throughput spheroid invasion assay quantification method.

Mungai R, Hartman 2nd R, Jolin G, Piskorowski K, Billiar K Sci Rep. 2024; 14(1):31007.

PMID: 39730859 PMC: 11681046. DOI: 10.1038/s41598-024-82191-3.


Bridging the Gap: Integrating 3D Bioprinting and Microfluidics for Advanced Multi-Organ Models in Biomedical Research.

De Spirito M, Palmieri V, Perini G, Papi M Bioengineering (Basel). 2024; 11(7).

PMID: 39061746 PMC: 11274229. DOI: 10.3390/bioengineering11070664.


Towards a More Objective and High-throughput Spheroid Invasion Assay Quantification Method.

Mungai R, Hartman Ii R, Jolin G, Piskorowski K, Billiar K bioRxiv. 2024; .

PMID: 39005385 PMC: 11244881. DOI: 10.1101/2024.06.27.600893.


Plant-derived extracellular nanovesicles: a promising biomedical approach for effective targeting of triple negative breast cancer cells.

Cui L, Perini G, Augello A, Palmieri V, De Spirito M, Papi M Front Bioeng Biotechnol. 2024; 12:1390708.

PMID: 38952670 PMC: 11215178. DOI: 10.3389/fbioe.2024.1390708.


Unraveling the potential of graphene quantum dots against infection.

Santarelli G, Perini G, Salustri A, Palucci I, Rosato R, Palmieri V Front Microbiol. 2024; 15:1395815.

PMID: 38774507 PMC: 11107295. DOI: 10.3389/fmicb.2024.1395815.


References
1.
Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y . Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci. 2020; 7:193. PMC: 7468194. DOI: 10.3389/fmolb.2020.00193. View

2.
Norouzi M, Yathindranath V, Thliveris J, Kopec B, Siahaan T, Miller D . Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Sci Rep. 2020; 10(1):11292. PMC: 7347880. DOI: 10.1038/s41598-020-68017-y. View

3.
Pickl M, Ries C . Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene. 2008; 28(3):461-8. DOI: 10.1038/onc.2008.394. View

4.
Liu H, Li C, Qian Y, Hu L, Fang J, Tong W . Magnetic-induced graphene quantum dots for imaging-guided photothermal therapy in the second near-infrared window. Biomaterials. 2019; 232:119700. DOI: 10.1016/j.biomaterials.2019.119700. View

5.
Pieragostino D, DAlessandro M, Di Ioia M, Di Ilio C, Sacchetta P, Del Boccio P . Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases. Proteomics Clin Appl. 2014; 9(1-2):169-86. DOI: 10.1002/prca.201400084. View